Timaq bought by Irish CRO Icon

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organization, Positron emission tomography

CRO Icon acquires Timaq Medical Imaging to expand its clinical trial imaging services offering

In a statement accompanying the news, Icon said that Timaq’s European headquarters, in Zurich, Switzerland, and links with medical institutions were key motivations for the acquisition.

Icon spokeswoman Emily Brand declined to say how much the Irish contract research organisation (CRO) had paid for Timaq, but did tell Outsourcing-pharma how the firm plans to work with its new purchase.

She predicted that Timaq's integration into Icon’s existing medical imaging unit, which is headquartered in Warrington in Pennsylvania, US, will take place over the next six to 12 months.

Brand went on to say that: “Icon will also relocate some personnel to Zurich to assist the integration process and provide day to day support​,” but did not say how many employees would be involved.

Timaq founder and Positron emission tomography computed tomography (PET-CT) pioneer, Professor Gustav von Schulthess from University Hospital Zurich, welcomed the deal.

Together we can enhance and expand the range of imaging services we offer our clients, while Icon’s global footprint will enable us to support the largest multi-country imaging studies​.”

While medical imaging has long been established as a diagnostic tool, demand for the technique in clinical trials has increased markedly in recent years as sponsors seek to reduce trial costs.

The basic idea is that imaging analysis during trials provides more rapid and detailed feedback to sponsors, enabling them to more readily identify which clinical programmes represent the best value.

This has seen a number of contract research firm’s invest in the field, ranging Perceptive Informatics technology acquisition last year​ to Covance’s new early-stage R&D services​ unit.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Related suppliers

Follow us


View more